Furthermore, ectopic STK33 also partially rescued VEGF promoter activity (Figure 6C) as well as VEGF secretion (Figure 6D and Supplementary Figure 4A) in hypoxic cancer cells subjected to HSP90 inhibition. This evidence concerns the gene VEGFA and cancer.